Effects of a New Cardiotonic Phosphodiesterase III Inhibitor, Olprinone, on Cardiohemodynamics and Plasma Hormones in Conscious Pigs with Heart Failure-Reference-Cited by-同舟云学术

Effects of a New Cardiotonic Phosphodiesterase III Inhibitor, Olprinone, on Cardiohemodynamics and Plasma Hormones in Conscious Pigs with Heart Failure

Published:1997-06 Issue:6 Volume:29 Page:763-771
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Adachi Hideyuki,Tanaka Hiroshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference30 articles.

1. A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart Failure

2. Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

3. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.

4. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.

5. Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stabilization of Kv1.5 channel protein by the inotropic agent olprinone;European Journal of Pharmacology;2015-10

2. Population pharmacokinetics of olprinone in healthy male volunteers;Clinical Pharmacology: Advances and Applications;2014-03

3. Method Development and Validation of Olprinone in Human Plasma by HPLC Coupled with ESI-MS-MS: Application to a Pharmacokinetic Study;Journal of Chromatographic Science;2013-05-19

4. Population pharmacokinetics of olprinone in patients undergoing cardiac surgery with cardiopulmonary bypass;Journal of Anesthesia;2012-10-23

5. The phosphodiesterase III inhibitor olprinone inhibits hippocampal glutamate release via a cGMP/PKG pathway;Neuroscience Letters;2008-12